期刊文献+

缓释前列腺素E2对MC3T3-E1细胞成骨基因表达的影响

Effect of sustained releasing prostaglandin E2 on osteogenic gene expression of MC3T3-E1 cells
原文传递
导出
摘要 目的探讨载前列腺素E2(prostaglandin E2,PGE2)的乳酸-羟基乙酸共聚物微球(PLGA-PGE2-MSs)对成骨样细胞株MC3T3-E1成骨因子表达的影响。方法采用膜乳化-溶剂挥发法制备粒径均匀的PGE2-PLGA微球。以无添加物培养基(n=6)、空白微球(n=6)为对照组;PGE2(n=6)及缓释PLGA-PGE2-MSs(n=6)为实验组。PGE2浓度为0.0125、0.0500、0.2000、0.8000μmol/L的各实验组与成骨样细胞株MC3T3-E1孵育5、7、9、11 d;采用RT-PCR检测不同时间成骨因子的表达水平。结果微球对照组与空白对照组各时间点比较差异无统计学意义(P>0.05);不同浓度的PGE2、PLGA-PGE2-MSs组与空白对照组同一时间点比较,均能促进RUNX2、ALP、OPN基因表达水平(P<0.05);相同PGE2浓度水平的两个实验组同一时间点比较,PLGA-PGE2-MSs组促进基因表达水平高于PGE2组(P<0.05)。结论PLGA-PGE2-MSs具有明显的缓释作用;在本研究设定的浓度区间内,PGE2、PLGA-PGE2-MSs均可促进MC3T3-E1细胞增殖、分化、基质成熟等不同阶段代表性基因RUNX2、ALP、OPN的表达水平。 Objective To explore the effect of PLGA microspheres loaded with prostaglandin E2(PLGA-PGE2-MSs)on the expression of osteogenic factor from osteoblast-like cell line MC3T3-E1.Methods PGE2-PLGA-MSs with uniform particle size were prepared by membrane emulsification solvent evaporation method.No additive medium(n=6)and blank microsphere(n=6)were used as control group,PGE2(n=6)and sustained releasing PLGA-PGE2-MSs(n=6)were used as experimental group.Each experimental group with PGE2 concentration of 0.0125,0.0500,0.2000,and 0.8000μmol/L was incubated with the osteoblast-like cell line MC3T3-E1 for 5,7,9,and 11 days,and the expression level of osteogenic factor was detected by RT-PCR at different time.Results There was no significant difference between microsphere control group and blank control group at each time point(P>0.05);Compared with the blank control group at the same time point,different concentrations of PGE2 and sustained releasing PLGA-PGE2-MSs could promote the expression of Runx2,ALP and OPN genes(P<0.05).At the same time point,in the two experimental groups with the same PGE2 concentration level,the expression level of gene in the sustained releasing PLGA-PGE2-MSs group was higher than that in the PGE2 group(P<0.05).Conclusions PLGA-PGE2-MSs have obvious sustained releasing effect.Within the concentration range set in this study,PGE2 and PLGA-PGE2-MSs can promote the expression level of Runx2,ALP and OPN in MC3T3-E1 cells at different stages of proliferation,differentiation and matrixmaturation.
作者 白艳洁 徐晖 白雪涛 李亚莹 BAI Yan-jie;XU Hui;BAI Xue-tao;LI Ya-ying(Department of Stomatology,People's Hospital of Liaoning Province,Shenyang 110016,China)
出处 《中国美容整形外科杂志》 CAS 2019年第11期701-703,I0014,I0015,共5页 Chinese Journal of Aesthetic and Plastic Surgery
基金 辽宁省自然科学基金(201602423) 沈阳市科技人才应用技术研究计划(18-014-4-21)
关键词 前列腺素E2 缓释微球 成骨样细胞 基因表达 Prostaglandin E2 Sustained releasingmicrospheres Osteoblast like cells Gene expression
  • 相关文献

参考文献1

二级参考文献9

  • 1Lagarce F, Cruaud O, Deuschel C. Oxaliplatin loaded PLAGA microspheres : design of specific release profiles [ J ]. Int J Pharm, 2002,242(1-2) :243-246. 被引量:1
  • 2Jackson JK, Hung T, Letchfi rd K, et al. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly (lactic-co-glycolic acid ) (PLGA) and low molecular weight diblock copolymers [ J ]. Int J Pharm, 2007,342 ( 1-2 ) :6-17. 被引量:1
  • 3Gupte A, Ciftci K. Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres [ J ]. Int J Pharm, 2004,276(1-2) :93-106. 被引量:1
  • 4Liggins RT, Burr HM. Paclitaxel-loaded poly (l-lactic acid ) mi- crospheres 3 : blending low and high molecular weight polymers to control morphology and drug release [ J ]. lnt J Pharm, 2004, 282(1-2) :61-71. 被引量:1
  • 5Roberto Nicolete R, Lima Kde M, JOnior JM, et al. Prostaglandin E(2 )-loaded microspheres as strategy to inhibit phagocytosis and modulate inflammatory mediators release[ J]. Eur J Pharm Biop- harm, 2008,70(3 ) :784-790. 被引量:1
  • 6Park S J , Kim SH. Preparation and characterization of biodegrad- able poly ( 1-1actide )/poly ( ethylene glycol) micro-capsules con- taining erythromycin by emulsion solvent evaporation techniq ue[J]. J Colloid Interface Sci , 2004,271 (2) :336-341. 被引量:1
  • 7Gang R, Si SF. Preparation and characterization of poly( lactic acid)- poly ( ethyleneglycol )-poly ( lactic acid ) ( PLA2PEG2PLA ) micro- spheres for controlled release of paclitaxel [J ]. Biomaterials, 2003, 24(27) :5037-5044. 被引量:1
  • 8Uludage H, Gao T, Porter TJ, et al. Delivory systems for BMPs: factors contributing to protein retention at an application site[ J ]. J bone joint Surg Am, 2001,83-A Suppl 1 ( Pt 2) :S128-S135. 被引量:1
  • 9Watzer B, Zehbe R, Halstenberg S, et al. Stability of prostaglandin E2 (PGF2) embedded in poly-d, 1-1actide-co-glycolide nficro- spheres: a pre-conditioning approach for tissue engineering applica- tions[J]. J Mater Sci Mater Med, 21309,20 (6) :1357-1365. 被引量:1

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部